Article Text

Download PDFPDF
CASE REPORT
Sestamibi scintigraphy for parathyroid localisation: a reminder of the dangers of false positives
  1. Katherine Lisa Whitcroft,
  2. Anup Sharma
  1. St George's Healthcare NHS Trust, London, UK
  1. Correspondence to Katherine Lisa Whitcroft, k.whitcroft{at}gmail.com

Summary

Surgical parathyroidectomy is the only curative treatment for primary hyperparathyroidism. As minimally invasive parathyroidectomy increases in popularity, so does reliance on preoperative parathyroid localisation techniques. One such technique is sestamibi scintigraphy. We report a case of false-positive sestamibi scintigraphy caused by follicular variant of papillary thyroid carcinoma. Subsequent completion thyroidectomy was not possible due to widespread postoperative fibrosis. This case, therefore, highlights the potential dangers of false-positive results due to thyroid carcinoma and encourages surgeons to consider this possibility when faced with intrathyroidal or otherwise ambiguous parathyroid localisation results.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.